General Surgery

Deliverer of light to MIS surgical sites, Invuity, Inc. has announced an agreement with one of the U.S.’ most prominent and nationally recognized purchasing organizations, Yankee Alliance, that will see its products being made available to thousands of its members.

CareFusion says its new line of Micro-Laparoscopic instruments means it is on trend with miniaturized procedures.

If FDA supports its advisory panel’s less than unanimous endorsement, EnteroMedics’ VBLOC will be the first device to be approved for Obesity treatment in ten years.

New data further demonstrate the acute effects of EndoBarrier® Therapy on glycemic control, its ability to reduce reliance on diabetes medications and potential mechanism of action.

U.S Registry data suggests that GERD treatment using EndoGastric Solutions’ TIF procedure will be successful in patients with persistent symptoms despite use of PPI therapy.

A cyanoacrylate adhesive device designed for hernia mesh fixation under a Development and Pre-Supply Agreement between Surgical Innovations And AMS, has received CE approval.

15 members of staff from Leeds-based device company Surgical Innovations are to cycle the route of the first stage in a bid to raise money for local charity The Sick Children’s Trust.

Ethicon Endo-Surgery has launched its HARMONIC ACE®+7 Shears with Advanced Hemostasis, the first purely ultrasonic device with a 7 mm sealing indication. It claims the system outperforms its rival LigaSure™device when it comes to burst pressure.

Surgical adhesive specialist Cohera Medical, Inc.®, has applied for CE Mark approval for Sylys® Surgical Sealant, the first synthetic sealant designed specifically to help reduce anastomotic leaks in gastrointestinal procedures. The company says approval is expected by the end of 2014.

A new “swallowable” GI imaging device device has the potential to safely produce high-resolution images of the colon without requiring patients to go through the bowel cleansing process beforehand, says data presented at a research forum during DDW2014.

Robotically assisted surgery is in the spotlight again as one commentator says it doesn’t justify its cost. Our weekly editorial discusses whether providers have much choice about whether to invest if they’re to remain current and competitive.

Medigus Ltd., a medical device company developing minimally-invasive, endosurgical tools and procedures, points us at two presentations at last week’s Digestive Disease® Week annual meeting, involving the use of its MUSE™ System for transoral fundoplication.

GI Dynamics is trumpeting new data from a study performed with GlaxoSmithKline, presented at Digestive Disease Week 2014 (DDW). Bile Acid increases, as experienced with Roux-en-Y Gastric Bypass, may explain weight loss and glucose stabilization,

EndoGastric Solutions® recently released data supporting its Transoral Incisionless Fundoplication (TIF®) procedure for treating Gastro-Esophageal Reflux Disease (GERD. Now the company has announced that it has a new President and CEO in the form of industry veteran, Skip Baldino.

EndoGastric Solutions® (EGS), says newly released data demonstrates that its Transoral Incisionless Fundoplication (TIF®) procedure outperforms proton pump inhibitor (PPI) treatment, while achieving similar normalization rates of distal esophageal acid exposure.

The EndoStim LES Stimulation System has received CE Mark approval for use with Magnetic Resonance Imaging (MRI), and is now conditionally approved for MRI scans of head and extremities.